Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera's management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Nateratm is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

These press releases may also interest you

at 12:31
Commons Clinic proudly announces that four of its esteemed physicians have been named to Newsweek's prestigious list of 150 Best Spine Surgeons in America for 2024. This recognition underscores the clinic's commitment to providing top-tier spinal...

at 12:20
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) today announced voting results for its 2024 annual general meeting (the Meeting) of shareholders held on June 14, 2024. Shareholders re-elected five of nine incumbent directors to the Board of...

at 12:05
The Police Benevolent Association of the City of New York (PBA) has been honored with the Kidneys for Communities National Community Impact Award in recognition of its dedication and commitment to promoting living kidney donation and supporting the...

at 12:01
INITIATION NOTE: BrainStorm Cell Therapeutics Inc.  is focused on developing autologous mesenchymal stem cell (MSC) therapies for the treatment of neurodegenerative diseases (NDDs) ? BCLI's primary...

at 12:01
The board of directors of Abbott today declared a quarterly common dividend of 55 cents per share. This marks the 402nd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2024, to shareholders of...

at 12:00
Sleep Doctor, the leading online source for sleep health, improvement, and education, has published a recent survey report examining the relationship between sleep and work. The report also provides insights into the sleep disparities between men and...

News published on and distributed by: